GSK submits lupus drug for EU approval

06/7/2010 | Reuters

GlaxoSmithKline submitted a marketing application to the European Medicines Agency for its lupus drug candidate Benlysta. The drugmaker, which co-develops Benlysta with Human Genome Sciences, also plans to file for FDA approval of the treatment later this month.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID